MEI Pharma (MEIP) Reports Q2 EPS of $0.32

MEI Pharma (NASDAQ: MEIP) reported Q2 EPS of $0.32, versus ($0.15) reported last year. Revenue for the quarter came in at $17.1 million, versus $0 reported last year.

For earnings history and earnings-related data on MEI Pharma (MEIP) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• Truist Securities Starts Matthews International (MATW) at Hold, 'We see risk/reward as more balanced'
• Needham Reiterates Buy Rating on Napco Security Technologies, Inc. (NSSC)